Compare · LGMK vs STE
LGMK vs STE
Side-by-side comparison of LogicMark Inc. (LGMK) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LGMK and STE operate in Industrial Specialties (Health Care), so they compete in similar markets.
- STE carries a market cap of $20.52B.
- Over the past year, LGMK is up 0.0% and STE is down 13.6% - LGMK leads by 13.6 points.
- STE has been more active in the news (16 items in the past 4 weeks vs 4 for LGMK).
- STE has more recent analyst coverage (16 ratings vs 0 for LGMK).
- Company
- LogicMark Inc.
- STERIS plc (Ireland)
- Price
- $0.01-6.67%
- $210.28+0.27%
- Market cap
- -
- $20.52B
- 1M return
- +0.00%
- -0.96%
- 1Y return
- +0.00%
- -13.61%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 4
- 16
- Recent ratings
- 0
- 16
LogicMark Inc.
LogicMark, Inc. offers personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company, through its subsidiary, LogicMark LLC, manufactures and distributes non-monitored and monitored personal emergency response systems sold through healthcare durable medical equipment and monitored security dealers/distributors, and the United States Department of Veterans Affairs. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest LGMK
- LogicMark Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-Q filed by LogicMark Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by LogicMark Inc.
- LogicMark, Inc. Announces Strong First Quarter 2026 Results
- LogicMark, Inc. to Announce First Quarter 2026 Financial Results on May 13, 2026
- LogicMark Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form POS EX filed by LogicMark Inc.
- SEC Form POS EX filed by LogicMark Inc.
- SEC Form 10-K filed by LogicMark Inc.
- LogicMark, Inc. Announces Strong Fourth Quarter and Full Year 2025 Results
Latest STE
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam covered exercise/tax liability with 337 units of Ordinary Shares, decreasing direct ownership by 1% to 33,332 units (SEC Form 4)
- V.P. & Corporate Treasurer Tamaro Renato covered exercise/tax liability with 81 units of Ordinary Shares, decreasing direct ownership by 1% to 5,614 units (SEC Form 4)
- VP, Chf. Comp. & Quality Offc. Mcgowan Lindsey covered exercise/tax liability with 198 units of Ordinary Shares, decreasing direct ownership by 4% to 4,830 units (SEC Form 4)
- SVP and President, Healthcare Majors Cary L covered exercise/tax liability with 768 units of Ordinary Shares, decreasing direct ownership by 6% to 12,659 units (SEC Form 4)
- Sr. VP and GM, Life Sciences Madsen Julia covered exercise/tax liability with 208 units of Ordinary Shares, decreasing direct ownership by 2% to 10,502 units (SEC Form 4)
- SVP & GM, AST Kohler Kenneth E covered exercise/tax liability with 109 units of Ordinary Shares, decreasing direct ownership by 1% to 9,533 units (SEC Form 4)
- SVP & Chief HRO Fraser Mary Clare covered exercise/tax liability with 673 units of Ordinary Shares, decreasing direct ownership by 5% to 12,209 units (SEC Form 4)
- Sr. Vice Pres., CFO Burton Karen L covered exercise/tax liability with 99 units of Ordinary Shares, decreasing direct ownership by 1% to 8,205 units (SEC Form 4)
- President and CEO Carestio Daniel A covered exercise/tax liability with 1,254 units of Ordinary Shares, decreasing direct ownership by 2% to 49,842 units (SEC Form 4)
- SEC Form 144 filed by STERIS plc (Ireland)